Skip to main navigation Skip to search Skip to main content

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients with Type 2 Diabetes

Project: Research

Project Details

StatusFinished
Effective start/end date09/20/1611/30/20

Funding

  • AstraZeneca Pharmaceuticals LP: $123,072.00